Machina Capital’s Roivant Sciences ROIV Stock Holding History

Machina Capital’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.04M	Buy	29,460 +4,290	+17%	+$127K	0.17%	190
2026 Q1	$697K	Buy	+25,170	New	+$647K	0.14%	199

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Machina Capital's ROIV Position: Q2 2026 in Review

Machina Capital increased its Roivant Sciences (ROIV) stake by 17% in Q2 2026, buying an estimated $127K and bringing the position to 29,460 shares worth $1.04M. The position accounts for 0.17% of the portfolio, ranked #190.

Machina Capital first reported a position in ROIV in Q1 2026 and has held it in 2 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

Machina Capital held 29,460 shares of Roivant Sciences worth $1.04M as of Q2 2026.
Machina Capital bought 4,290 Roivant Sciences shares in Q2 2026, an estimated $127K.
Roivant Sciences made up 0.17% of Machina Capital's portfolio in Q2 2026, its #190 holding.
Machina Capital first reported a position in Roivant Sciences in Q1 2026 and has held it in 2 quarters since.
498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Machina Capital's 13F filing for Q2 2026, filed 10 Aug 2026.